In vivo Genome Editing Therapeutic Approaches for Neurological Disorders: Where Are We in the Translational Pipeline?
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
In vivo Genome Editing Therapeutic Approaches for Neurological Disorders: Where Are We in the Translational Pipeline?
Authors
Keywords
-
Journal
Frontiers in Neuroscience
Volume 15, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-02-21
DOI
10.3389/fnins.2021.632522
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- In vivo CRISPRa decreases seizures and rescues cognitive deficits in a rodent model of epilepsy
- (2020) Gaia Colasante et al. BRAIN
- Treatment of a Mouse Model of ALS by In Vivo Base Editing
- (2020) Colin K.W. Lim et al. MOLECULAR THERAPY
- In Vitro CRISPR/Cas9-Directed Gene Editing to Model LRRK2 G2019S Parkinson’s Disease in Common Marmosets
- (2020) Scott C. Vermilyea et al. Scientific Reports
- CRISPR deletion of the C9ORF72 promoter in ALS/FTD patient motor neurons abolishes production of dipeptide repeat proteins and rescues neurodegeneration
- (2020) Gopinath Krishnan et al. ACTA NEUROPATHOLOGICA
- Gene editing and CRISPR in the clinic: current and future perspectives
- (2020) Matthew P. Hirakawa et al. BIOSCIENCE REPORTS
- CRISPR-Based Therapeutic Genome Editing: Strategies and In Vivo Delivery by AAV Vectors
- (2020) Dan Wang et al. CELL
- Glia-to-Neuron Conversion by CRISPR-CasRx Alleviates Symptoms of Neurological Disease in Mice
- (2020) Haibo Zhou et al. CELL
- Reactivation of FMR1 gene expression is a promising strategy for fragile X syndrome therapy
- (2020) Ekaterina M. Shitik et al. GENE THERAPY
- Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors
- (2020) Andrew V. Anzalone et al. NATURE BIOTECHNOLOGY
- CRISPR/dCas9-based Scn1a gene activation in inhibitory neurons ameliorates epileptic and behavioral phenotypes of Dravet syndrome model mice
- (2020) Tetsushi Yamagata et al. NEUROBIOLOGY OF DISEASE
- Recent advances in gene therapy for neurodevelopmental disorders with epilepsy
- (2020) Thomas J. Turner et al. JOURNAL OF NEUROCHEMISTRY
- Cas9 gene therapy for Angelman syndrome traps Ube3a-ATS long non-coding RNA
- (2020) Justin M. Wolter et al. NATURE
- Modulating gene regulation to treat genetic disorders
- (2020) Navneet Matharu et al. NATURE REVIEWS DRUG DISCOVERY
- Genome Editing for CNS Disorders
- (2020) Fábio Duarte et al. Frontiers in Neuroscience
- In vivo neuronal gene editing via CRISPR–Cas9 amphiphilic nanocomplexes alleviates deficits in mouse models of Alzheimer’s disease
- (2019) Hanseul Park et al. NATURE NEUROSCIENCE
- Editing the Central Nervous System Through CRISPR/Cas9 Systems
- (2019) Agustin Cota-Coronado et al. Frontiers in Molecular Neuroscience
- dCas9-based Scn1a gene activation restores inhibitory interneuron excitability and attenuates seizures in Dravet syndrome mice
- (2019) Gaia Colasante et al. MOLECULAR THERAPY
- Search-and-replace genome editing without double-strand breaks or donor DNA
- (2019) Andrew V. Anzalone et al. NATURE
- Advances in genome editing through control of DNA repair pathways
- (2019) Charles D. Yeh et al. NATURE CELL BIOLOGY
- CRISPR/Cas9 Mediated Disruption of the Swedish APP Allele as a Therapeutic Approach for Early-Onset Alzheimer’s Disease
- (2018) Bence György et al. Molecular Therapy-Nucleic Acids
- Downregulation of SNCA Expression by Targeted Editing of DNA Methylation: A Potential Strategy for Precision Therapy in PD
- (2018) Boris Kantor et al. MOLECULAR THERAPY
- Cas9 immunity creates challenges for CRISPR gene editing therapies
- (2018) Julie M. Crudele et al. Nature Communications
- CRISPR-mediated activation of a promoter or enhancer rescues obesity caused by haploinsufficiency
- (2018) Navneet Matharu et al. SCIENCE
- CRISPR/Cas9-mediated gene editing ameliorates neurotoxicity in mouse model of Huntington’s disease
- (2017) Su Yang et al. JOURNAL OF CLINICAL INVESTIGATION
- Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage
- (2017) Nicole M. Gaudelli et al. NATURE
- Virus-Mediated Genome Editing via Homology-Directed Repair in Mitotic and Postmitotic Cells in Mammalian Brain
- (2017) Jun Nishiyama et al. NEURON
- Targeted DNA methylation in human cells using engineered dCas9-methyltransferases
- (2017) Tina Xiong et al. Scientific Reports
- Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing
- (2016) Angelo Amabile et al. CELL
- Editing DNA Methylation in the Mammalian Genome
- (2016) X. Shawn Liu et al. CELL
- In vivo genome editing via CRISPR/Cas9 mediated homology-independent targeted integration
- (2016) Keiichiro Suzuki et al. NATURE
- Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
- (2016) Alexis C. Komor et al. NATURE
- Targeted DNA demethylation in vivo using dCas9–peptide repeat and scFv–TET1 catalytic domain fusions
- (2016) Sumiyo Morita et al. NATURE BIOTECHNOLOGY
- Repurposing the CRISPR-Cas9 system for targeted DNA methylation
- (2016) Aleksandar Vojta et al. NUCLEIC ACIDS RESEARCH
- Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems
- (2016) K. Nishida et al. SCIENCE
- Reprogrammable CRISPR/Cas9-based system for inducing site-specific DNA methylation
- (2016) James I. McDonald et al. Biology Open
- A CRISPR-based approach for targeted DNA demethylation
- (2016) Xingxing Xu et al. Cell Discovery
- Reactivation of FMR1 by CRISPR/Cas9-Mediated Deletion of the Expanded CGG-Repeat of the Fragile X Chromosome
- (2016) Nina Xie et al. PLoS One
- Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex
- (2015) Silvana Konermann et al. NATURE
- Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers
- (2015) Isaac B Hilton et al. NATURE BIOTECHNOLOGY
- Highly efficient Cas9-mediated transcriptional programming
- (2015) Alejandro Chavez et al. NATURE METHODS
- Highly specific epigenome editing by CRISPR-Cas9 repressors for silencing of distal regulatory elements
- (2015) Pratiksha I Thakore et al. NATURE METHODS
- Reversion of FMR1 Methylation and Silencing by Editing the Triplet Repeats in Fragile X iPSC-Derived Neurons
- (2015) Chul-Yong Park et al. Cell Reports
- Off-target Effects in CRISPR/Cas9-mediated Genome Engineering
- (2015) Xiao-Hui Zhang et al. Molecular Therapy-Nucleic Acids
- Enhanced homology-directed human genome engineering by controlled timing of CRISPR/Cas9 delivery
- (2014) Steven Lin et al. eLife
- Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression
- (2013) Lei S. Qi et al. CELL
- CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering
- (2013) Prashant Mali et al. NATURE BIOTECHNOLOGY
- RNA-guided gene activation by CRISPR-Cas9–based transcription factors
- (2013) Pablo Perez-Pinera et al. NATURE METHODS
- Efficient construction of sequence-specific TAL effectors for modulating mammalian transcription
- (2011) Feng Zhang et al. NATURE BIOTECHNOLOGY
- Modularly assembled designer TAL effector nucleases for targeted gene knockout and gene replacement in eukaryotes
- (2011) Ting Li et al. NUCLEIC ACIDS RESEARCH
- A TALE nuclease architecture for efficient genome editing
- (2010) Jeffrey C Miller et al. NATURE BIOTECHNOLOGY
- Breaking the Code of DNA Binding Specificity of TAL-Type III Effectors
- (2009) J. Boch et al. SCIENCE
- A Simple Cipher Governs DNA Recognition by TAL Effectors
- (2009) M. J. Moscou et al. SCIENCE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More